Positron Emission Tomography of 64Cu-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL
- 10 January 2012
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 14 (5) , 608-616
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CTEJNMMI Research, 2011
- Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibodyNuclear Medicine and Biology, 2011
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast CancerClinical Pharmacology & Therapeutics, 2010
- ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies)Protein Engineering, Design and Selection, 2010
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PETJournal of Nuclear Medicine, 2009
- A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole AntibodiesBioconjugate Chemistry, 2007
- Mechanisms of killing by anti-CD20 monoclonal antibodiesMolecular Immunology, 2007
- Positron-Emission Tomography and Assessment of Cancer TherapyNew England Journal of Medicine, 2006
- Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid for radiolabeling proteinsNuclear Medicine and Biology, 2003
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978